AMGEN

Amgen Inc.

Trademark Registered: 2020-06-16
Trademark Application Details
Trademark Logo AMGEN

Status


807
Live/Pending
SU - NON-FINAL ACTION - MAILED
Research OneLook Acronym Finder
Serial Number86834490
Registration Number6080333
Mark Drawing Code4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Attorney NameTimothy J. Gaul
Attorney Docket NumberTM-1009-US-6
Law Office AssignedN20
Employee NameTOY, JOSHUA SPENCER JO

Timeline

1990-01-01Date of First Use
2015-11-30Application Filed
2016-08-16Published for Opposition
2019-10-28Location: TMO LAW OFFICE 120 - EXAMINING ATTORNEY ASSIGNED
2019-10-28Status: Live/Pending
2019-10-28Transaction Date
2020-06-16Trademark Registered

Trademark Applicants & Owners

Owner: Amgen Inc.
AddressOne Amgen Center Drive Trademark Operations - MS-28-5A Thousand Oaks DE 913201799
Legal Entity TypeCorporation
Legal Entity StateDE

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

Timothy J. Gaul
Amgen Inc.
One Amgen Center Drive
Trademark Operations
Thousand Oaks, CA 91320-1799

Good, Services, and Codes

International Codes:5
U.S. Codes:006,018,044,046,051,052
International Codes:10
U.S. Codes:026,039,044
International Codes:35
U.S. Codes:100,101,102
International Codes:36
U.S. Codes:100,101,102
International Codes:41
U.S. Codes:100,101,107
International Codes:42
U.S. Codes:100,101
International Codes:44
U.S. Codes:100,101
Type CodeType
GS0051House mark for a full line of pharmaceuticals; pharmaceutical preparations for the treatment of anemia, ankylosing spondylitis, arthritis, cancer, cardiovascular conditions, collection by leukopheresis, effects of myelosuppressive chemotherapy, effects of myelosuppressive doses of radiation, glandular disorders, hormone disorders, hypercalcemia, hyperparathyroidism, hyperphosphatemia, kidney disorders and disease, migraine, neutropenia, osteoporosis, parathyroid disorders, psoriasis, reduction of red blood cell transfusions, renal disorders, thrombocytopenia; prescription pharmaceuticals for the treatment of anemia, ankylosing spondylitis, arthritis, cancer, cardiovascular conditions, collection by leukopheresis, effects of myelosuppressive chemotherapy, effects of myelosuppressive doses of radiation, glandular disorders, hormone disorders, hypercalcemia, hyperparathyroidism, hyperphosphatemia, kidney disorders and disease, migraine, neutropenia, osteoporosis, parathyroid disorders, psoriasis, reduction of red blood cell transfusions, renal disorders, thrombocytopenia; and pre-filled syringes and vials containing pharmaceutical preparations for the treatment of the aforementioned diseases and disorders and complications associated therewith
GS0051Pharmaceuticals for the treatment of cardiovascular, cancer, bone, neurological nephrological and inflammation disease and disorders; pharmaceutical preparations for the treatment of anemia, ankylosing spondylitis, arthritis, cancer, cardiovascular conditions, collection by leukopheresis, effects of myelosuppressive chemotherapy, effects of myelosuppressive doses of radiation, glandular disorders, hormone disorders, hypercalcemia, hyperparathyroidism, hyperphosphatemia, kidney disorders and disease, migraine, neutropenia, osteoporosis, parathyroid disorders, psoriasis, reduction of red blood cell transfusions, renal disorders, thrombocytopenia; prescription pharmaceuticals for the treatment of anemia, ankylosing spondylitis, arthritis, cancer, cardiovascular conditions, collection by leukopheresis, effects of myelosuppressive chemotherapy, effects of myelosuppressive doses of radiation, glandular disorders, hormone disorders, hypercalcemia, hyperparathyroidism, hyperphosphatemia, kidney disorders and disease, migraine, neutropenia, osteoporosis, parathyroid disorders, psoriasis, reduction of red blood cell transfusions, renal disorders, thrombocytopenia; and pre-filled syringes and vials containing pharmaceutical preparations for the treatment of the aforementioned diseases and disorders and complications associated therewith

Trademark Filing History

DescriptionDateEvent Coding
NEW APPLICATION ENTERED IN TRAM2015-12-031 NWAP I:Incoming Correspondence
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2015-12-042 NWOS I:Incoming Correspondence
ASSIGNED TO EXAMINER2016-01-073 DOCK D:Assigned to Examiner
NON-FINAL ACTION WRITTEN2016-01-084 CNRT R:Renewal
NON-FINAL ACTION E-MAILED2016-01-085 GNRT F:First Action
NOTIFICATION OF NON-FINAL ACTION E-MAILED2016-01-086 GNRN O:Outgoing Correspondence
TEAS RESPONSE TO OFFICE ACTION RECEIVED2016-04-207 TROA I:Incoming Correspondence
CORRESPONDENCE RECEIVED IN LAW OFFICE2016-04-208 CRFA I:Incoming Correspondence
TEAS/EMAIL CORRESPONDENCE ENTERED2016-04-219 TEME I:Incoming Correspondence
FINAL REFUSAL WRITTEN2016-05-1110 CNFR R:Renewal
FINAL REFUSAL E-MAILED2016-05-1111 GNFR O:Outgoing Correspondence
NOTIFICATION OF FINAL REFUSAL EMAILED2016-05-1112 GNFN O:Outgoing Correspondence
EXAMINERS AMENDMENT -WRITTEN2016-07-1313 CNEA R:Renewal
EXAMINERS AMENDMENT E-MAILED2016-07-1314 GNEA O:Outgoing Correspondence
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED2016-07-1315 GNEN O:Outgoing Correspondence
EXAMINER'S AMENDMENT ENTERED2016-07-1316 XAEC I:Incoming Correspondence
APPROVED FOR PUB - PRINCIPAL REGISTER2016-07-1417 CNSA P:
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2016-07-2718 NONP E:E-Mail
PUBLISHED FOR OPPOSITION2016-08-1619 PUBO A:Allowance for Publication
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2016-08-1620 NPUB E:E-Mail
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2016-10-1121 NOAM E:E-Mail
TEAS EXTENSION RECEIVED2017-03-2722 EEXT I:Incoming Correspondence
EXTENSION 1 FILED2017-03-2723 EXT1 S:
EXTENSION 1 GRANTED2017-03-2724 EX1G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2017-03-2925 EXRA E:E-Mail
TEAS EXTENSION RECEIVED2017-08-3126 EEXT I:Incoming Correspondence
CASE ASSIGNED TO INTENT TO USE PARALEGAL2017-09-1227 AITU A:Allowance for Publication
EXTENSION 2 FILED2017-08-3128 EXT2 S:
EXTENSION 2 GRANTED2017-09-1229 EX2G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2017-09-1330 EXRA E:E-Mail
TEAS EXTENSION RECEIVED2018-03-1331 EEXT I:Incoming Correspondence
EXTENSION 3 FILED2018-03-1332 EXT3 S:
EXTENSION 3 GRANTED2018-03-1533 EX3G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2018-03-1634 EXRA E:E-Mail
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2018-08-0235 REAP I:Incoming Correspondence
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2018-08-0236 ARAA I:Incoming Correspondence
TEAS EXTENSION RECEIVED2018-09-0737 EEXT I:Incoming Correspondence
EXTENSION 4 FILED2018-09-0738 EXT4 S:
EXTENSION 4 GRANTED2018-09-0739 EX4G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2018-09-1140 EXRA E:E-Mail
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2019-03-0741 REAP I:Incoming Correspondence
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2019-03-0742 ARAA I:Incoming Correspondence
TEAS EXTENSION RECEIVED2019-03-2843 EEXT I:Incoming Correspondence
EXTENSION 5 FILED2019-03-2844 EXT5 S:
EXTENSION 5 GRANTED2019-04-0345 EX5G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2019-04-0446 EXRA E:E-Mail
TEAS STATEMENT OF USE RECEIVED2019-10-1047 EISU I:Incoming Correspondence
USE AMENDMENT FILED2019-10-1048 IUAF S:
STATEMENT OF USE PROCESSING COMPLETE2019-10-1249 SUPC I:Incoming Correspondence
SU - NON-FINAL ACTION - WRITTEN2019-10-2850 CNRT W:
NON-FINAL ACTION E-MAILED2019-10-2851 GNRT O:Outgoing Correspondence
NOTIFICATION OF NON-FINAL ACTION E-MAILED2019-10-2852 GNRN O:Outgoing Correspondence
TEAS RESPONSE TO OFFICE ACTION RECEIVED2020-04-2853 TROA I:Incoming Correspondence
CORRESPONDENCE RECEIVED IN LAW OFFICE2020-04-2854 CRFA I:Incoming Correspondence
TEAS/EMAIL CORRESPONDENCE ENTERED2020-04-2955 TEME I:Incoming Correspondence
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED2020-05-1456 CNPR P:
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED2020-05-1557 SUNA E:E-Mail
REGISTERED-PRINCIPAL REGISTER2020-06-1658 R.PR A:Allowance for Publication
TEAS CHANGE OF OWNER ADDRESS RECEIVED2022-04-2959 COAR I:Incoming Correspondence
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2022-04-2960 REAP I:Incoming Correspondence
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2022-04-2961 ARAA I:Incoming Correspondence
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS2022-04-2962 EWAF I:Incoming Correspondence
TEAS CHANGE OF CORRESPONDENCE RECEIVED2022-04-2963 TCCA I:Incoming Correspondence
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED2022-04-2964 CHAN I:Incoming Correspondence

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed